|
|
450 Duane Avenue Schenectady, NY 12304 USA phone:518-381-1000 fax:518-381-4400
|
|
| Symbol |
Private |
| Founded |
1999 |
| Employees |
|
|
|
| www.cardiomag.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Makes cardiac diagnostic devices |
 |
| Management |
| Carl H. Rosner, Chairman and Chief Executive Officer; Tush P. Nikollaj, President and Chief Operating Officer; Alexander A. Bakharev, Sr. Vice President, New Product Development; Robert S. Sokolowski, Ph.D, Vice President, Business Development; Steven Karr, Ph.D, Project Manager, Regulatory Affairs; Barbara Polidore, Financial Controller |
| |
|
|
| |
|
| Keywords |
| cardiology, diagnostics, adv2007, advamed |
|
|
|
| Description |
|
CardioMag Imaging, Inc. (CMI) is engaged in the development and commercialization of its novel cardiac diagnostic device, which is based on the integration of highly sophisticated proprietary sensors, electronics, and software. |
 |
| Products / Services |
CMI's new and unique MagnetoCardioGraph (MCG) heart diagnostic systems can be used in practical clinical settings for the safe, non-invasive, and early detection of abnormalities in the human heart. The company designs and manufactures its systems in a fully integrated facility with capabilities for cryogenic and electronics production, machining, curing ovens, painting, clean room, test facilities and software development.
|
 |
| Technology / Differentiation |
| CardioMag's MCG system is the world's first and only MCG system to obtain FDA approval. The basis of the device relies on analyzing magnetic fields generated by the heart's electrical activity. From the MCG analysis of ventricular repolarization alone, the physician can tell whether a patient has underlying coronary artery disease and-using beat-to-beat analysis-the relative risk of sudden cardiac death. |
 |
| Market / Customers |
Several systems are currently in clinical trials in hospitals and medical centers in the United States, Germany and Italy.
|
 |
| Status |
| This is the world's first MCG system to obtain FDA approval for use as a tool for cardiac investigations. |
 |
|
|
|
|
|
|